Cambridge Investment Research Advisors
NOVT icon

Cambridge Investment Research Advisors’s Novanta NOVT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Buy
2,436
+255
+12% +$36.9K ﹤0.01% 3186
2026
Q1 		$258K Buy
2,181
+125
+6% +$16.4K ﹤0.01% 3418
2025
Q4 		$245K Buy
+2,056
New +$234K ﹤0.01% 3395

Other funds holding NOVT

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
CRC
Catawba River Capital Lake Wylie, South Carolina $223M AUM 24.34% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return

Cambridge Investment Research Advisors's NOVT Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Novanta (NOVT) stake by 12% in Q2 2026, buying an estimated $36.9K and bringing the position to 2,436 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #3186.

Cambridge Investment Research Advisors first reported a position in NOVT in Q4 2025 and has held it in 3 quarters since. 104 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Cambridge Investment Research Advisors held 2,436 shares of Novanta worth $395K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 255 Novanta shares in Q2 2026, an estimated $36.9K.
  • Novanta made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3186 holding.
  • Cambridge Investment Research Advisors first reported a position in Novanta in Q4 2025 and has held it in 3 quarters since.
  • 104 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.